Caxton Associates LP Relay Therapeutics, Inc. Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.9 - $8.02 $137,163 - $186,448	-23,248 Reduced 17.77%	107,568 $701,000
Q1 2024 May 15, 2024	SELL	$7.5 - $12.07 $1.11 Million - $1.79 Million	-148,285 Reduced 53.13%	130,816 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$6.01 - $11.48 $1.45 Million - $2.77 Million	241,247 Added 637.31%	279,101 $3.07 Million
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $311,916 - $490,966	37,854 New	37,854 $318,000

204

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.